Triumeq Tablet, Film Coated
Product Images NDC 49702-231

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Triumeq (NDC 49702-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ziagen Chem Structure (Triumeq Spl Graphic 01)

FDA Label Image

Dolutegravir Chemical Structure (Triumeq Spl Graphic 02)

FDA Label Image

Epivir Chem Struc (Triumeq Spl Graphic 03)

FDA Label Image

Triumeq 30 Count Carton (Triumeq Spl Graphic 04)

FDA Label Image

Triumeq Spl Graphic 05

This is a table in a "Water Volume Guide" that shows the number of effervescent tablets needed to be dissolved in 20mL of water. Unfortunately, there is no information provided for volumes or numbers of tablets beyond those presented in the table.*

FDA Label Image

Triumeq Spl Graphic 06

FDA Label Image

Triumeq Spl Graphic 07

FDA Label Image

Triumeq Spl Graphic 08

FDA Label Image

Triumeq Spl Graphic 09

Each tablet of NDC 49702-231-13 contains abacavir, dolutegravir sodium, and lamivudine. Abacavir and dolutegravir treat HIV while lamivudine helps prevent hepatitis B. This medication comes in a child-resistant package and must be stored at controlled room temperature. The prescribing information provides dosage instructions, and a medication guide should be given to the patient along with a warning card.*

FDA Label Image

Triumeq Spl Graphic 10

Triumeq P is a medication for oral suspension containing abacavir, dolutegravir, and lamivudine. It is available in bottles containing 90 tablets of 60 mg/5 mg/30 mg strength accompanied by a dosing cup, prescribing information, and medication guide. Triumeq and Triumeq PD are not interchangeable. Authorized dispensers must give patients a Medication Guide and Warning Card from the carton each time TRIUMEQ PD is dispensed. Dosage information is available in the prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.